Skip to content

Study · In vitro (cell-free) · 1989

2 results

[Comparative study of the effect of the thymus preparations thymoptin and thymalin on fibrin-monomer polymerization].

Pastorova VE, Liapina LA, Ashmarin IP, Kudriashov BA, Zazhireĭ VD

Farmakologiia i toksikologiia1 Mar 1989

PMID2744143 (opens in a new tab)PepBankPUB-02744143
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cell-free)Activity measurement

    In vitro, thymalin possessed no nonenzymatic fibrinolytic activity.

    In plain wordsIn lab tests, thymalin had no nonenzymatic fibrin breakdown activity.

    Peptide
    Thymalin
    Outcome
    No significant changeNonenzymatic fibrinolytic activity
    Study

    n: not reported in source

    In vitro fibrin assays
    Outcome group
    Bleeding and clotting · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Thymalin possessed no nonenzymatic fibrinolytic activity in vitro
  2. 02LabIn vitro (cell-free)Activity measurement

    In vitro, thymalin enhanced fibrin-monomer polymerization at 1000 and 100 micrograms/ml, in contrast to thymoptin.

    In plain wordsIn lab tests, thymalin increased fibrin-monomer polymerization, in contrast to thymoptin.

    Peptide
    Thymalin
    Outcome
    IncreaseFibrin-monomer polymerization
    Study

    n: not reported in source

    In vitro fibrin assays
    Comparator
    Thymoptin
    Outcome group
    Bleeding and clotting · Cardiovascular
    Studied dose
    1000 and 100 micrograms/mlAs given in this study.

    Source sentences

    Summary
    Thymalin possessed no nonenzymatic fibrinolytic activity in vitro and in contrast to thymoptin at a relatively high concentration (1000 and 100 micrograms/ml) enhanced fibrin-monomer polymerization.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.